Picture of Cosmo NV logo

CMHC — Cosmo NV News Story

0.000.00%
ch flag iconLast trade - 00:00
HealthcareAdventurousMid CapSucker Stock

Brief: Cosmo Reports H1 Pretax Profit Of 3.7 Mln EUR Vs 9.1 Mln EUR Year Ago

July 26 (Reuters) - Cosmo Pharmaceuticals Nv  COPN.S :
    * COSMO PRESENTS STRONG H1 2023 OPERATIONAL AND FINANCIAL
RESULTS
    * H1 PRETAX PROFIT 3.7 MILLION EUR VERSUS 9.1 MILLION EUR
YEAR AGO
    * H1 EBITDA 14.0 MILLION EUR VERSUS 14.9 MILLION EUR YEAR
AGO
    * H1 OPERATING PROFIT 7.1 MILLION EUR VERSUS 8.1 MILLION EUR
YEAR
AGO
    * H1 REVENUE 43.7 MILLION EUR VERSUS 41.5 MILLION EUR YEAR
AGO
    * REAFFIRMATION OF FY 2023 GUIDANCE OF TOTAL REVENUES IN
RANGE OF
EUR 110 MILLION - EUR 120 MILLION
    * REAFFIRMATION OF FY 2023 GUIDANCE OF OPERATING PROFIT IN
RANGE
OF EUR 25 MILLION - EUR 35 MILLION

Source text for Eikon:  ID:nEQ8dxJ74a 
Further company coverage:  COPN.S 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Cosmo NV

See all news